|
Originally published In Press as doi:10.1074/jbc.M001758200 on April 14, 2000
J. Biol. Chem., Vol. 275, Issue 26, 19992-20001, June 30, 2000
Glucocorticoids Inhibit Developmental Stage-specific Osteoblast
Cell Cycle
DISSOCIATION OF CYCLIN A-CYCLIN-DEPENDENT KINASE 2 FROM
E2F4-p130 COMPLEXES*
Elisheva
Smith §,
Rebecca A.
Redman §,
Christopher R.
Logg ¶,
Gerhard A.
Coetzee **,
Nori
Kasahara ¶, and
Baruch
Frenkel § §§
From the Departments of  Orthopaedic
Surgery, Biochemistry and Molecular Biology,
¶ Pathology, Urology, § Institute for
Genetic Medicine and ** Norris Cancer Center, University of Southern
California Keck School of Medicine,
Los Angeles, California 90033
Unique cell cycle control is instituted in
confluent osteoblast cultures, driving growth to high density. The
postconfluent dividing cells share features with cells that normally
exit the cell cycle; p27kip1 is increased, p21waf1/cip1
is decreased, free E2F DNA binding activity is reduced, and E2F4 is
primarily nuclear. E2F4-p130 becomes the predominant E2F-pocket complex
formed on E2F sites, but, unlike the complex that typifies resting
cells, cyclin A and CDK2 are also present. Administration of
dexamethasone at this, but not earlier stages, results in reduction of
cyclin A and CDK2 levels with a parallel decrease in the
associated kinase activity, dissociation of cyclin A-CDK2 from the
E2F4-p130 complexes, and inhibition of G1/S
transition. The glucocorticoid-mediated cell cycle attenuation is also
accompanied by, but not attributable to, increased p27kip1 and
decreased p21waf1/cip1 levels. The attenuation of osteoblast
growth to high density by dexamethasone is associated with severe
impairment of mineralized extracellular matrix formation, unless
treatment commences in cultures that have already grown to high
density. Both the antimitotic and the antiphenotypic effects are
reversible, and both are antagonized by RU486. Thus, glucocorticoids
induce premature attenuation of the osteoblast cell cycle, possibly
contributing to the osteoporosis induced by these drugs in
vivo.
*
This work was supported by the Donald E. and Delia B. Baxter
Foundation, by the Wright Foundation, and by National Institutes of
Health Grant T32 CA 09659.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§§
To whom correspondence should be addressed: Inst. for Genetic
Medicine, University of Southern California Keck School of Medicine, 2250 Alcazar St., CSC/IGM240, Los Angeles, CA 90033. Tel.:
323-442-1322; Fax: 323-442-2764; E-mail: frenkel@hsc.usc.edu.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. J Rickard and M. J Young
Corticosteroid receptors, macrophages and cardiovascular disease
J. Mol. Endocrinol.,
June 1, 2009;
42(6):
449 - 459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Hamidouche, E. Hay, P. Vaudin, P. Charbord, R. Schule, P. J. Marie, and O. Fromigue
FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/{beta}-catenin signaling-dependent Runx2 expression
FASEB J,
November 1, 2008;
22(11):
3813 - 3822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Q. Yang, J. J. Rudiger, J. M. Hughes, S. Goulet, M. M. Gencay-Cornelson, P. Borger, M. Tamm, and M. Roth
Cell Density and Serum Exposure Modify the Function of the Glucocorticoid Receptor C/EBP Complex
Am. J. Respir. Cell Mol. Biol.,
April 1, 2008;
38(4):
414 - 422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-F. Iu, H. Kaji, H. Sowa, J. Naito, T. Sugimoto, and K. Chihara
Dexamethasone suppresses Smad3 pathway in osteoblastic cells
J. Endocrinol.,
April 1, 2005;
185(1):
131 - 138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-G. Bladh, J. Liden, A. Pazirandeh, I. Rafter, K. Dahlman-Wright, S. Nilsson, and S. Okret
Identification of Target Genes Involved in the Antiproliferative Effect of Glucocorticoids Reveals a Role for Nuclear Factor-{kappa}B Repression
Mol. Endocrinol.,
March 1, 2005;
19(3):
632 - 643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Eijken, M. Hewison, M. S. Cooper, F. H. de Jong, H. Chiba, P. M. Stewart, A. G. Uitterlinden, H. A. P. Pols, and J. P. T. M. van Leeuwen
11{beta}-Hydroxysteroid Dehydrogenase Expression and Glucocorticoid Synthesis Are Directed by a Molecular Switch during Osteoblast Differentiation
Mol. Endocrinol.,
March 1, 2005;
19(3):
621 - 631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Klees, R. M. Salasznyk, K. Kingsley, W. A. Williams, A. Boskey, and G. E. Plopper
Laminin-5 Induces Osteogenic Gene Expression in Human Mesenchymal Stem Cells through an ERK-dependent Pathway
Mol. Biol. Cell,
February 1, 2005;
16(2):
881 - 890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Smith and B. Frenkel
Glucocorticoids Inhibit the Transcriptional Activity of LEF/TCF in Differentiating Osteoblasts in a Glycogen Synthase Kinase-3{beta}-dependent and -independent Manner
J. Biol. Chem.,
January 21, 2005;
280(3):
2388 - 2394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Barski and B. Frenkel
ChIP Display: novel method for identification of genomic targets of transcription factors
Nucleic Acids Res.,
July 13, 2004;
32(12):
e104 - e104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sunters, D. P. Thomas, W. A. Yeudall, and A. E. Grigoriadis
Accelerated Cell Cycle Progression in Osteoblasts Overexpressing the c-fos Proto-oncogene: INDUCTION OF CYCLIN A AND ENHANCED CDK2 ACTIVITY
J. Biol. Chem.,
March 12, 2004;
279(11):
9882 - 9891.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Luppen, N. Leclerc, T. Noh, A. Barski, A. Khokhar, A. L. Boskey, E. Smith, and B. Frenkel
Brief Bone Morphogenetic Protein 2 Treatment of Glucocorticoid-inhibited MC3T3-E1 Osteoblasts Rescues Commitment-associated Cell Cycle and Mineralization without Alteration of Runx2
J. Biol. Chem.,
November 7, 2003;
278(45):
44995 - 45003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Westendorf, S. K. Zaidi, J. E. Cascino, R. Kahler, A. J. van Wijnen, J. B. Lian, M. Yoshida, G. S. Stein, and X. Li
Runx2 (Cbfa1, AML-3) Interacts with Histone Deacetylase 6 and Represses the p21CIP1/WAF1 Promoter
Mol. Cell. Biol.,
November 15, 2002;
22(22):
7982 - 7992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Consten, E.D. Keuning, J. Bogerd, M.A. Zandbergen, J.G.D. Lambert, J. Komen, and H.J.Th. Goos
Sex Steroids and Their Involvement in the Cortisol-Induced Inhibition of Pubertal Development in Male Common Carp, Cyprinus carpio L
Biol Reprod,
August 1, 2002;
67(2):
465 - 472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Smith, G. A. Coetzee, and B. Frenkel
Glucocorticoids Inhibit Cell Cycle Progression in Differentiating Osteoblasts via Glycogen Synthase Kinase-3beta
J. Biol. Chem.,
May 10, 2002;
277(20):
18191 - 18197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Logg, A. Logg, C.-K. Tai, P. M. Cannon, and N. Kasahara
Genomic Stability of Murine Leukemia Viruses Containing Insertions at the Env-3' Untranslated Region Boundary
J. Virol.,
August 1, 2001;
75(15):
6989 - 6998.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|